Design of Freeze-Drying Processes for Pharmaceuticals: Practical Advice

Design of freeze-drying processes is often approached with a “trial and error” experimental plan or, worse yet, the protocol used in the first laboratory run is adopted without further attempts at optimization. Consequently, commercial freeze-drying processes are often neither robust nor efficient. It is our thesis that design of an “optimized” freeze-drying process is not particularly difficult for most products, as long as some simple rules based on well-accepted scientific principles are followed. It is the purpose of this review to discuss the scientific foundations of the freeze-drying process design and then to consolidate these principles into a set of guidelines for rational process design and optimization. General advice is given concerning common stability issues with proteins, but unusual and difficult stability issues are beyond the scope of this review. Control of ice nucleation and crystallization during the freezing step is discussed, and the impact of freezing on the rest of the process and final product quality is reviewed. Representative freezing protocols are presented. The significance of the collapse temperature and the thermal transition, denoted Tg`, are discussed, and procedures for the selection of the “target product temperature” for primary drying are presented. Furthermore, guidelines are given for selection of the optimal shelf temperature and chamber pressure settings required to achieve the target product temperature without thermal and/or mass transfer overload of the freeze dryer. Finally, guidelines and “rules” for optimization of secondary drying and representative secondary drying protocols are presented.

[1]  P. Privalov,et al.  Cold Denaturation of Protein , 1990 .

[2]  J. Carpenter,et al.  Protein formulation and lyophilization cycle design: prevention of damage due to freeze-concentration induced phase separation. , 1999, Biotechnology and bioengineering.

[3]  M. Pikal,et al.  Mass and heat transfer in vial freeze-drying of pharmaceuticals: role of the vial. , 1984, Journal of pharmaceutical sciences.

[4]  Xinghang Ma,et al.  Characterization of Murine Monoclonal Antibody to Tumor Necrosis Factor (TNF-MAb) Formulation for Freeze-Drying Cycle Development , 2004, Pharmaceutical Research.

[5]  M. Pikal,et al.  Process control in freeze drying: determination of the end point of sublimation drying by an electronic moisture sensor. , 1989, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[6]  Michael J. Hageman,et al.  THE ROLE OF MOISTURE IN PROTEIN STABILITY , 1988 .

[7]  J. Carpenter,et al.  Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine T(g)' in pharmaceutical lyophilization. , 2001, Journal of pharmaceutical sciences.

[8]  Mackenzie Ap,et al.  Basic principles of freeze-drying for pharmaceuticals. , 1966 .

[9]  S J Prestrelski,et al.  Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. I. Enzyme activity and calorimetric studies. , 1993, Archives of biochemistry and biophysics.

[10]  H. Kramers Brownian motion in a field of force and the diffusion model of chemical reactions , 1940 .

[11]  T A Jennings,et al.  The effects of cooling rate on solid phase transitions and associated vial breakage occurring in frozen mannitol solutions. , 1986, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[12]  Michael J. Pikal,et al.  MECHANISMS OF PROTEIN STABILIZATION DURING FREEZE-DRYING AND STORAGE : THERELATIVE IMPORTANCE OF THERMODYNAMIC STABILIZATION AND GLASSY STATE RELAXAT ION DYNAMICS , 1999 .

[13]  J. Carpenter,et al.  The ice nucleation temperature determines the primary drying rate of lyophilization for samples frozen on a temperature-controlled shelf. , 2001, Journal of pharmaceutical sciences.

[14]  M. Pikal,et al.  Rubber closures as a source of haze in freeze dried parenterals: test methodology for closure evaluation. , 1978, Journal of the Parenteral Drug Association.

[15]  Shigeo Kojima,et al.  Phase Separation and Crystallization of Components in Frozen Solutions: Effect of Molecular Compatibility Between Solutes , 1997 .

[16]  S L Nail,et al.  Evaluation of manometric temperature measurement as a method of monitoring product temperature during lyophilization. , 1997, PDA journal of pharmaceutical science and technology.

[17]  Michael J. Pikal,et al.  Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice , 1997, Pharmaceutical Research.

[18]  A P Mackenzie,et al.  Basic principles of freeze-drying for pharmaceuticals. , 1966, Bulletin of the Parenteral Drug Association.

[19]  M. Pikal,et al.  Use of laboratory data in freeze drying process design: heat and mass transfer coefficients and the computer simulation of freeze drying. , 1985, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[20]  Michael J. Pikal,et al.  The collapse temperature in freeze drying: Dependence on measurement methodology and rate of water removal from the glassy phase , 1990 .

[21]  Raj Suryanarayanan,et al.  Crystallization of Mannitol below Tg′ during Freeze-Drying in Binary and Ternary Aqueous Systems , 2004, Pharmaceutical Research.

[22]  H Leuenberger,et al.  Formulations of sugars with amino acids or mannitol--influence of concentration ratio on the properties of the freeze-concentrate and the lyophilizate. , 1998, Pharmaceutical development and technology.

[23]  M. Pikal,et al.  Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone. , 1992, Developments in biological standardization.

[24]  P. Privalov,et al.  Heat and cold denaturation of phosphoglycerate kinase (interaction of domains) , 1989, FEBS letters.

[25]  F Franks,et al.  Salt precipitation during the freeze-concentration of phosphate buffer solutions. , 1989, Biophysical chemistry.

[26]  Michael J. Pikal,et al.  The secondary drying stage of freeze drying: drying kinetics as a function of temperature and chamber pressure☆ , 1990 .

[27]  B. Chang,et al.  Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. , 1996, Journal of pharmaceutical sciences.

[28]  E. Maltini Estimation of the viscosities of the frozen sucrose-water system from glass transition temperatures , 1993 .

[29]  Felix Franks,et al.  Changes in the physical state of model mixtures during freezing and drying : Impact on product quality , 1996 .

[30]  Pikal Mj,et al.  Rubber closures as a source of haze in freeze dried parenterals: test methodology for closure evaluation. , 1978 .

[31]  J. Carpenter,et al.  Application of a thermodynamic model to the prediction of phase separations in freeze-concentrated formulations for protein lyophilization. , 1999, Archives of biochemistry and biophysics.

[32]  Robert A. Lodder,et al.  Near-Infrared Spectroscopic Determination of Residual Moisture in Lyophilized Sucrose Through Intact Glass Vials , 1989, Pharmaceutical Research.

[33]  Michael J. Pikal,et al.  Thermophysical Properties of Pharmaceutically Compatible Buffers at Sub-Zero Temperatures: Implications for Freeze-Drying , 2002, Pharmaceutical Research.

[34]  M. Pikal,et al.  Physical chemistry of freeze-drying: measurement of sublimation rates for frozen aqueous solutions by a microbalance technique. , 1983, Journal of pharmaceutical sciences.

[35]  T. Sosnick,et al.  Viscosity dependence of the folding kinetics of a dimeric and monomeric coiled coil. , 1999, Biochemistry.

[36]  S L Nail,et al.  Effect of process conditions on recovery of protein activity after freezing and freeze-drying. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.